Insulet Corporation (PODD)
Technical, fundamental, and sentiment analysis with recent related videos.
PODD rates Neutral overall. The fundamental read is neutral: the company passes 4 of 9 quality tests on the Piotroski F-Score; balance sheet is in the Safe zone (Altman Z = 5.63); revenue is growing about 27.6% per year; net income is growing about 30.9% per year. The technical picture is neutral: price is 17.7% below the 200-day moving average; 6.1% above the 50-day; the 50/200 relationship is in a Death cross. Sentiment is bullish (composite 74/100), based on 6 news articles from recent coverage.
Revenue 3-year avg +27.6%. Net income 3-year avg +30.9%.
Price vs 20DMA +8.0%. RSI 66.26. Bollinger state: Inside Bands.
Composite score 74/100 from the AI judge, based on 6 news items, 0 television segments, and 0 videos.
Latest Market Read
Insulet’s three badges tell a mixed story. Fundamentals sit Neutral despite a three-year revenue average of +27.6% and net income averaging +30.9% per year, because net income trend has weakened and carries extra weight. Technical is Neutral: the Relative Strength Index (RSI), a momentum reading, is 66.3 and price is about 8.0% above the 20-day moving average, but the stock remains below its 200-day average and inside the Bollinger Bands, so the move lacks long-term confirmation. Sentiment is Bullish at 74/100, and the bullish buzz is real, but Neutral fundamental and technical readings keep the overall rating Neutral.
Recent news: The coverage is largely positive: multiple articles report Insulet's nationwide launch of Omnipod Discover, pre-rollout adoption by over 15,000 users and 1,800 clinicians, and early real-world data tying engagement to time-in-range gains for about one-third of participants, while shares have risen ~4.97% over 7 days and ~9.46% over 30 days. Sources agree the rollout and early clinical/engagement signals could boost retention and outcomes, but one law firm investigation into Insulet and a disclosed small insider sale introduce legal and sentiment risks that investors should watch.
Latest Videos
- No qualified videos yet.